These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [TBL] [Abstract][Full Text] [Related]
3. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results. Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932 [TBL] [Abstract][Full Text] [Related]
4. Clinical Utility of Intravascular Imaging: Past, Present, and Future. Mintz GS; Matsumura M; Ali Z; Maehara A JACC Cardiovasc Imaging; 2022 Oct; 15(10):1799-1820. PubMed ID: 36202460 [TBL] [Abstract][Full Text] [Related]
7. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds. Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830 [TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Ali ZA; Maehara A; Généreux P; Shlofmitz RA; Fabbiocchi F; Nazif TM; Guagliumi G; Meraj PM; Alfonso F; Samady H; Akasaka T; Carlson EB; Leesar MA; Matsumura M; Ozan MO; Mintz GS; Ben-Yehuda O; Stone GW; Lancet; 2016 Nov; 388(10060):2618-2628. PubMed ID: 27806900 [TBL] [Abstract][Full Text] [Related]
9. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials. Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283 [TBL] [Abstract][Full Text] [Related]
10. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel. Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654 [No Abstract] [Full Text] [Related]
11. Intravascular ultrasound-guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: Meta-analysis of randomized trials. Bavishi C; Sardar P; Chatterjee S; Khan AR; Shah A; Ather S; Lemos PA; Moreno P; Stone GW Am Heart J; 2017 Mar; 185():26-34. PubMed ID: 28267472 [TBL] [Abstract][Full Text] [Related]
12. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice. Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Pichard AD; Waksman R Arch Cardiovasc Dis; 2009 Feb; 102(2):143-51. PubMed ID: 19303582 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition. Attizzani GF; Capodanno D; Ohno Y; Tamburino C J Am Coll Cardiol; 2014 Apr; 63(14):1355-67. PubMed ID: 24530675 [TBL] [Abstract][Full Text] [Related]
14. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Otsuka F; Byrne RA; Yahagi K; Mori H; Ladich E; Fowler DR; Kutys R; Xhepa E; Kastrati A; Virmani R; Joner M Eur Heart J; 2015 Aug; 36(32):2147-59. PubMed ID: 25994755 [TBL] [Abstract][Full Text] [Related]
15. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: what have we learned from randomized-controlled clinical trials? Rizik DG; Hermiller JB; Simonton CA; Klassen KJ; Kereiakes DJ Coron Artery Dis; 2017 Jan; 28(1):77-89. PubMed ID: 27561169 [TBL] [Abstract][Full Text] [Related]
16. Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. Haude M; Ince H; Abizaid A; Toelg R; Lemos PA; von Birgelen C; Christiansen EH; Wijns W; Neumann FJ; Kaiser C; Eeckhout E; Lim ST; Escaned J; Garcia-Garcia HM; Waksman R Lancet; 2016 Jan; 387(10013):31-9. PubMed ID: 26470647 [TBL] [Abstract][Full Text] [Related]
17. Intravascular ultrasound versus optical coherence tomography guidance. Waksman R; Kitabata H; Prati F; Albertucci M; Mintz GS J Am Coll Cardiol; 2013 Oct; 62(17 Suppl):S32-40. PubMed ID: 24135661 [No Abstract] [Full Text] [Related]